We gratefully acknowledge Dr. Kenneth Pienta (Johns Hopkins, MD) for providing TMAs from prostate cancer patients for immunohistochemical analyses of FABP4 expression and Dr. Dong Ping Shi (WSU, Karmanos Cancer Institute) for histopathological evaluation of TMAs. The gene discussed is FABP4; the disease is prostate carcinoma.